HRP20110524T1 - Spojevi dihidropiridina za neurodegenerativne bolesti i demenciju - Google Patents
Spojevi dihidropiridina za neurodegenerativne bolesti i demenciju Download PDFInfo
- Publication number
- HRP20110524T1 HRP20110524T1 HR20110524T HRP20110524T HRP20110524T1 HR P20110524 T1 HRP20110524 T1 HR P20110524T1 HR 20110524 T HR20110524 T HR 20110524T HR P20110524 T HRP20110524 T HR P20110524T HR P20110524 T1 HRP20110524 T1 HR P20110524T1
- Authority
- HR
- Croatia
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- disease
- hydrate
- patient
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title claims abstract 8
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 3
- 230000004770 neurodegeneration Effects 0.000 title abstract 2
- 125000004925 dihydropyridyl group Chemical class N1(CC=CC=C1)* 0.000 title 1
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 claims abstract 14
- 208000024827 Alzheimer disease Diseases 0.000 claims abstract 7
- 229960003530 donepezil Drugs 0.000 claims abstract 7
- 208000028698 Cognitive impairment Diseases 0.000 claims abstract 5
- 208000010877 cognitive disease Diseases 0.000 claims abstract 5
- PRMWGUBFXWROHD-UHFFFAOYSA-N perampanel Chemical compound O=C1C(C=2C(=CC=CC=2)C#N)=CC(C=2N=CC=CC=2)=CN1C1=CC=CC=C1 PRMWGUBFXWROHD-UHFFFAOYSA-N 0.000 claims abstract 4
- 208000023105 Huntington disease Diseases 0.000 claims abstract 3
- 208000018737 Parkinson disease Diseases 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims 19
- 150000001875 compounds Chemical class 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- MMWRGWQTAMNAFC-UHFFFAOYSA-N 1,2-Dihydropyridine Natural products C1NC=CC=C1 MMWRGWQTAMNAFC-UHFFFAOYSA-N 0.000 abstract 3
- -1 1,2-dihydropyridine compounds Chemical class 0.000 abstract 3
- 239000000544 cholinesterase inhibitor Substances 0.000 abstract 3
- 229940098747 AMPA receptor antagonist Drugs 0.000 abstract 2
- 239000000775 AMPA receptor antagonist Substances 0.000 abstract 2
- 239000002664 nootropic agent Substances 0.000 abstract 2
- 230000001777 nootropic effect Effects 0.000 abstract 2
- 229940122041 Cholinesterase inhibitor Drugs 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66766505P | 2005-04-04 | 2005-04-04 | |
US68951905P | 2005-06-13 | 2005-06-13 | |
PCT/US2006/012284 WO2006107859A2 (en) | 2005-04-04 | 2006-04-04 | Dihydropyridine compounds for neurodegenerative diseases and dementia |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20110524T1 true HRP20110524T1 (hr) | 2011-08-31 |
Family
ID=37074003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110524T HRP20110524T1 (hr) | 2005-04-04 | 2011-07-12 | Spojevi dihidropiridina za neurodegenerativne bolesti i demenciju |
Country Status (16)
Country | Link |
---|---|
US (3) | US20090131480A1 (ja) |
EP (2) | EP1871369A4 (ja) |
JP (2) | JP5180816B2 (ja) |
KR (1) | KR20080007233A (ja) |
AT (1) | ATE511843T1 (ja) |
AU (1) | AU2006232517A1 (ja) |
CA (1) | CA2603258A1 (ja) |
CY (1) | CY1112427T1 (ja) |
DK (1) | DK1871368T3 (ja) |
HR (1) | HRP20110524T1 (ja) |
IL (1) | IL186412A0 (ja) |
ME (1) | ME01224B (ja) |
PL (1) | PL1871368T3 (ja) |
PT (1) | PT1871368E (ja) |
RS (1) | RS51822B (ja) |
WO (2) | WO2006107860A2 (ja) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4614884B2 (ja) * | 2003-11-14 | 2011-01-19 | シャンハイ ゲノミックス インク | ピリドンの誘導体とその使用 |
CA2603258A1 (en) * | 2005-04-04 | 2006-10-12 | Eisai Co., Ltd. | Dihydropyridine compounds and compositions for headaches |
US20090030017A1 (en) * | 2005-04-08 | 2009-01-29 | Eisai R & D Management Co., Ltd | Therapeutic agent for dyskinesia |
PL1928454T3 (pl) | 2005-05-10 | 2015-03-31 | Intermune Inc | Pochodne pirydonu do modulowania układu kinazy białkowej aktywowanego stresem |
WO2007126060A1 (ja) * | 2006-04-28 | 2007-11-08 | Eisai R & D Management Co., Ltd | 1,2-ジヒドロピリジン化合物の塩 |
MX2009004516A (es) * | 2006-10-27 | 2009-08-12 | Medivation Neurology Inc | Metodos y terapias de combinacion para tratar enfermedad de alzheimer. |
AU2008210455A1 (en) | 2007-01-31 | 2008-08-07 | Vertex Pharmaceuticals Incorporated | 2-aminopyridine derivatives useful as kinase inhibitors |
US20100099714A1 (en) * | 2007-03-05 | 2010-04-22 | Eisai R&D Management Co., Ltd. | AMPA and NMDA Receptor Antagonists for Neurodegenerative Diseases |
US20100168174A1 (en) * | 2007-07-13 | 2010-07-01 | Eisai R&D Management Co., Ltd. | Combination of AMPA Receptor Antagonists and Acetylcholinesterase Inhibitors for the Treatment of Neuropathic Pain |
WO2009054543A1 (en) * | 2007-10-26 | 2009-04-30 | Eisai R & D Management Co., Ltd. | Ampa receptor antagonists and zonisamide for parkinson's disease and movement disorders |
US20100297181A1 (en) * | 2007-12-26 | 2010-11-25 | Eisai R&D Management Co., Ltd. | AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ |
US20090221554A1 (en) * | 2008-02-28 | 2009-09-03 | Zenyaku Kogyo Kabushiki Kaisha | Method of treating cognitive impairment |
US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
CA3034994A1 (en) | 2008-06-03 | 2009-12-10 | Intermune, Inc. | Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders |
US8569337B2 (en) | 2008-07-23 | 2013-10-29 | Vertex Pharmaceuticals Incorporated | Tri-cyclic pyrazolopyridine kinase inhibitors |
JP5631310B2 (ja) | 2008-07-23 | 2014-11-26 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | 三環式ピラゾロピリジンキナーゼ阻害剤 |
CN102131807B (zh) | 2008-07-23 | 2013-11-20 | 沃泰克斯药物股份有限公司 | 吡唑并吡啶激酶抑制剂 |
AU2009279611A1 (en) | 2008-08-06 | 2010-02-11 | Vertex Pharmaceuticals Incorporated | Aminopyridine kinase inhibitors |
WO2010072605A1 (en) | 2008-12-23 | 2010-07-01 | F. Hoffmann-La Roche Ag | Dihydropyridone amides as p2x7 modulators |
MX2011006843A (es) | 2008-12-23 | 2011-08-04 | Hoffmann La Roche | Dihidropiridona-amidas como moduladores de p2x7. |
US8153808B2 (en) | 2008-12-23 | 2012-04-10 | Roche Palo Alto Llc | Dihydropyridone amides as P2X7 modulators |
JP2012513435A (ja) | 2008-12-23 | 2012-06-14 | エフ.ホフマン−ラ ロシュ アーゲー | P2x7調節薬としてのジヒドロピリドンアミド |
EP2385939A1 (en) | 2008-12-23 | 2011-11-16 | F. Hoffmann-La Roche AG | Dihydropyridone amides as p2x7 modulators |
CA2760705A1 (en) | 2009-05-06 | 2010-11-11 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridines |
MX2012008644A (es) | 2010-01-27 | 2012-11-23 | Vertex Pharma | Inhibidores de cinasa de pirazolopiridinas. |
AU2011209651A1 (en) | 2010-01-27 | 2012-08-09 | Vertex Pharmaceuticals Incorporated | Pyrazolopyrimidine kinase inhibitors |
AU2011209649A1 (en) | 2010-01-27 | 2012-08-09 | Vertex Pharmaceuticals Incorporated | Pyrazolopyrazine kinase inhibitors |
JO2998B1 (ar) | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
CA2850166C (en) | 2011-09-27 | 2019-12-03 | Amgen Inc. | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
DK2849781T3 (en) | 2012-03-12 | 2017-10-16 | William J Binder | TREATMENT OF MIGRINE HEAD PAIN WITH PRESYNAPTIC NEUROTOXIN |
US8722060B2 (en) * | 2012-05-23 | 2014-05-13 | William J. Binder | Method of treating vertigo |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
TW201441193A (zh) | 2012-12-06 | 2014-11-01 | Kyowa Hakko Kirin Co Ltd | 吡啶酮化合物 |
US11407721B2 (en) | 2013-02-19 | 2022-08-09 | Amgen Inc. | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
WO2014134201A1 (en) | 2013-02-28 | 2014-09-04 | Amgen Inc. | A benzoic acid derivative mdm2 inhibitor for the treatment of cancer |
CA2906538C (en) | 2013-03-14 | 2021-02-02 | Ana Gonzalez Buenrostro | Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer |
JOP20200296A1 (ar) | 2013-06-10 | 2017-06-16 | Amgen Inc | عمليات صنع وأشكال بلورية من mdm2 مثبط |
KR102373700B1 (ko) | 2014-04-02 | 2022-03-11 | 인터뮨, 인크. | 항섬유성 피리디논 |
US10703746B2 (en) | 2014-12-22 | 2020-07-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mutant IDH1 inhibitors useful for treating cancer |
RU2742173C2 (ru) * | 2016-04-26 | 2021-02-02 | Х. Лундбекк А/C | Применение ингибитора ацетилхолинэстеразы и идалопирдина для снижения риска падений у пациентов с болезнью паркинсона |
US11364225B2 (en) * | 2019-08-21 | 2022-06-21 | Bn Intellectual Properties, Inc. | Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same |
WO2023042887A1 (ja) * | 2021-09-15 | 2023-03-23 | 国立大学法人 琉球大学 | 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物 |
WO2023042888A1 (ja) * | 2021-09-15 | 2023-03-23 | 国立大学法人 琉球大学 | 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物 |
WO2023230205A1 (en) | 2022-05-25 | 2023-11-30 | Ikena Oncology, Inc. | Mek inhibitors and uses thereof |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
US5262165A (en) | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
JP3075566B2 (ja) | 1990-05-15 | 2000-08-14 | エーザイ株式会社 | 光学活性インダノン誘導体 |
JP2965675B2 (ja) | 1990-11-21 | 1999-10-18 | エーザイ株式会社 | (―)―1―ベンジル―4―〔(5,6―ジメトキシ―1―インダノン)―2―イル〕メチルピペリジンの製造方法 |
US6010715A (en) | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
US5843945A (en) | 1993-05-13 | 1998-12-01 | Neurosearch A/S | AMPA antagonists and a method of treatment |
DE4428835A1 (de) * | 1994-08-01 | 1996-02-08 | Schering Ag | Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
PL181532B1 (pl) * | 1994-09-27 | 2001-08-31 | Yamanouchi Pharma Co Ltd | Pochodne 1,2,3,4-tetrahydrochinoksalinodionu PL PL PL PL PL PL PL PL PL |
HU228434B1 (en) | 1995-06-07 | 2013-03-28 | Ortho Mcneil Pharm Inc | Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
WO1997046526A1 (en) * | 1996-06-07 | 1997-12-11 | Eisai Co., Ltd. | Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
TW513409B (en) * | 1996-06-07 | 2002-12-11 | Eisai Co Ltd | Polymorphs of donepezil hydrochloride |
WO1998017672A1 (de) * | 1996-10-24 | 1998-04-30 | Novartis Ag | Substituierte aminoalkanphosphonsäuren |
JP4095676B2 (ja) * | 1997-03-03 | 2008-06-04 | エーザイ株式会社 | 注意障害を治療するためのコリンエステラーゼ阻害剤の使用 |
US6060479A (en) * | 1997-06-09 | 2000-05-09 | Pfizer Inc | Quinazoline-4-one AMPA antagonists |
US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
DE69822218T2 (de) * | 1997-12-05 | 2005-02-03 | Eisai Co., Ltd. | Donepezil polykristalle und verfharen zu ihrer herstellung |
JP2002505288A (ja) | 1998-03-02 | 2002-02-19 | コセンシス,インコーポレイテッド | 置換キナゾリンおよびアナログならびにそれらの使用 |
IT1304904B1 (it) * | 1998-09-11 | 2001-04-05 | Eisai Co Ltd | Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche |
FR2805260A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP2003525903A (ja) * | 2000-03-03 | 2003-09-02 | エーザイ株式会社 | コリンエステラーゼ阻害剤の新規使用法 |
US20030153598A1 (en) * | 2000-07-25 | 2003-08-14 | Raymond Pratt | Methods for treating Parkinson's disease with cholinesterase inhibitors |
US20060183776A9 (en) * | 2000-03-03 | 2006-08-17 | Eisai Co., Ltd. | Liquid dosage formulations of donepezil |
US20030144255A1 (en) * | 2000-03-06 | 2003-07-31 | Bain Allen I | Compositions for prevention and treatment of dementia |
ATE420862T1 (de) * | 2000-06-12 | 2009-01-15 | Eisai R&D Man Co Ltd | 1,2-dihydropyridinverbindungen, verfahren zu deren herstellung und deren verwendung |
JP2002047272A (ja) * | 2000-07-26 | 2002-02-12 | Dai Ichi Seiyaku Co Ltd | ポリアミンアミド誘導体 |
HU228961B1 (en) * | 2000-09-18 | 2013-07-29 | Eisai R & D Man Co | Triazinones and their use as active ingredients of pharmaceutical compositions |
WO2003024456A1 (en) * | 2001-09-20 | 2003-03-27 | Eisai Co., Ltd. | Methods for treating and preventing migraines |
GB0129260D0 (en) * | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
AU2003298514A1 (en) * | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
JP4208512B2 (ja) * | 2002-07-23 | 2009-01-14 | 株式会社クラレ | 5−(2’−ピリジル)−2−ピリドン誘導体の製造方法 |
JP2004189706A (ja) * | 2002-12-13 | 2004-07-08 | Eisai Co Ltd | 高度アルツハイマー型痴呆治療剤 |
MY148809A (en) * | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
CA2603258A1 (en) * | 2005-04-04 | 2006-10-12 | Eisai Co., Ltd. | Dihydropyridine compounds and compositions for headaches |
-
2006
- 2006-04-04 CA CA002603258A patent/CA2603258A1/en not_active Abandoned
- 2006-04-04 ME MEP-2011-133A patent/ME01224B/me unknown
- 2006-04-04 EP EP06749149A patent/EP1871369A4/en not_active Withdrawn
- 2006-04-04 US US11/887,729 patent/US20090131480A1/en not_active Abandoned
- 2006-04-04 US US11/396,621 patent/US20060276510A1/en not_active Abandoned
- 2006-04-04 PL PL06740387T patent/PL1871368T3/pl unknown
- 2006-04-04 AU AU2006232517A patent/AU2006232517A1/en not_active Abandoned
- 2006-04-04 DK DK06740387.3T patent/DK1871368T3/da active
- 2006-04-04 WO PCT/US2006/012285 patent/WO2006107860A2/en active Application Filing
- 2006-04-04 WO PCT/US2006/012284 patent/WO2006107859A2/en active Application Filing
- 2006-04-04 PT PT06740387T patent/PT1871368E/pt unknown
- 2006-04-04 US US11/396,555 patent/US20060270709A1/en not_active Abandoned
- 2006-04-04 AT AT06740387T patent/ATE511843T1/de active
- 2006-04-04 JP JP2008505417A patent/JP5180816B2/ja not_active Expired - Fee Related
- 2006-04-04 EP EP06740387A patent/EP1871368B1/en active Active
- 2006-04-04 JP JP2008505418A patent/JP2008537552A/ja not_active Withdrawn
- 2006-04-04 RS RS20110318A patent/RS51822B/en unknown
- 2006-04-04 KR KR1020077025426A patent/KR20080007233A/ko not_active Application Discontinuation
-
2007
- 2007-10-07 IL IL186412A patent/IL186412A0/en unknown
-
2011
- 2011-07-12 HR HR20110524T patent/HRP20110524T1/hr unknown
- 2011-07-29 CY CY20111101013T patent/CY1112427T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008537552A (ja) | 2008-09-18 |
US20090131480A1 (en) | 2009-05-21 |
WO2006107859A2 (en) | 2006-10-12 |
EP1871368A4 (en) | 2009-11-11 |
EP1871368B1 (en) | 2011-06-08 |
PL1871368T3 (pl) | 2011-12-30 |
EP1871369A2 (en) | 2008-01-02 |
WO2006107860A3 (en) | 2009-04-09 |
US20060270709A1 (en) | 2006-11-30 |
JP2008538216A (ja) | 2008-10-16 |
EP1871369A4 (en) | 2009-11-11 |
RS51822B (en) | 2012-02-29 |
US20060276510A1 (en) | 2006-12-07 |
CY1112427T1 (el) | 2015-12-09 |
DK1871368T3 (da) | 2011-09-19 |
IL186412A0 (en) | 2008-08-07 |
EP1871368A2 (en) | 2008-01-02 |
WO2006107859A3 (en) | 2009-04-09 |
AU2006232517A1 (en) | 2006-10-12 |
WO2006107859A8 (en) | 2007-11-08 |
PT1871368E (pt) | 2011-08-30 |
ME01224B (me) | 2013-06-20 |
CA2603258A1 (en) | 2006-10-12 |
KR20080007233A (ko) | 2008-01-17 |
WO2006107860A2 (en) | 2006-10-12 |
JP5180816B2 (ja) | 2013-04-10 |
ATE511843T1 (de) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20110524T1 (hr) | Spojevi dihidropiridina za neurodegenerativne bolesti i demenciju | |
MA28706B1 (fr) | Antagoniste des recepteurs du glucagon, preparation et utilisations therapeutiques | |
ATE502017T1 (de) | Pyrazolderivate als p2x7-modulatoren | |
JP2012508734A5 (ja) | ||
WO2008111590A3 (en) | Ampa and nmda receptor antagonists for neurodegenerative diseases | |
MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
WO2007003330A3 (de) | Pharmazeutische darreichungsformen enthaltend eine wirkstoffkombination von nifedipin und/oder nisoldipin und einem angiotensin-ii antagonisten | |
WO2008092072A3 (en) | Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof | |
HRP20200872T1 (hr) | Kombinacija čistih antagonista 5-ht6 receptora sa inhibitorima acetilholinesteraze | |
JP2017531692A5 (ja) | ||
TN2009000452A1 (en) | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof | |
JP2013518914A5 (ja) | ||
WO2007092861A3 (en) | Inhibitors specific of presenilin-1 and their uses | |
NZ594369A (en) | Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases | |
MX2021007780A (es) | Composiciones y metodos para tratar trastornos neurodegenerativos. | |
JP2016514688A5 (ja) | ||
TW200732304A (en) | Piperidine derivatives | |
HRP20201412T1 (hr) | Trostruka kombinacija čistih antagonista receptora 5-ht6, inhibitora acetilkolinesteraze i antagonista receptora nmda | |
EA036542B9 (ru) | Галоген-замещенные пиперидины в качестве модуляторов орексинового рецептора | |
NZ611529A (en) | Glucagon receptor modulators | |
MX2021003508A (es) | Derivados de 5-azaindazol como antagonistas del receptor de adenosina. | |
JP2013536206A5 (ja) | ||
KR100599350B1 (ko) | 알츠하이머 치매와 같은 노인성 치매 치료용의 활성 성분들, 특히, 테트라히드로피리딘류 및 아세틸콜린에스테라아제 억제제의 배합물 | |
MX2009000762A (es) | 4-arilalcoximetil-4-fenil piperidinas y su uso como antagonistas del receptor de neuroquinina para el tratamiento de trastornos del sistema nervioso central. | |
RU2013147196A (ru) | Агонист рецептора 5-нт4 в качестве прокинетического агента |